Long-term high-dose interferon-α therapy delays Hepadnavirus-related hepatocarcinogenesis in X/myc transgenic mice (Q44796636)

6 December 2017

Long-term high-dose interferon-alpha therapy delays Hepadnavirus-related hepatocarcinogenesis in X/myc transgenic mice (English)

1 reference

6 December 2017

Long-term high-dose interferon-α therapy delays Hepadnavirus-related hepatocarcinogenesis in X/myc transgenic mice (English)

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206375

1 January 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743599

1 January 2024

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206375

1 January 2024

author name string

Philippe Merle

1

1 reference

6 December 2017

Luc Barraud

2

1 reference

6 December 2017

Lydie Lefrançois

3

1 reference

6 December 2017

Michele Chevallier

4

1 reference

6 December 2017

Sylviane Guerret

5

1 reference

6 December 2017

Mireille Maisonnas

6

1 reference

6 December 2017

Isabelle Bordes

7

1 reference

6 December 2017

Isabelle Savre-Train

8

1 reference

6 December 2017

Christian Trepo

9

1 reference

6 December 2017

Ludmila Vitvitski-Trepo

10

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

6 December 2017

8 May 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12743599

full work available at URL

1 January 2024

https://www.nature.com/articles/1206375.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206375

https://www.nature.com/articles/1206375

1 January 2024

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206375

1 January 2024

1 reference

6 December 2017

22

1 reference

6 December 2017

18

1 reference

6 December 2017

2762-2771

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1206375

6 December 2017

0 references

cites work

Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206375

Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206375

Genetics of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206375

Inhibition of cell proliferation in HCC-9204 hepatoma cells by a c-myc specific ribozyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206375

Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206375

Why do so many cancer patients fail to respond to interferon therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206375

Close link between reduction of c-myc expression by interferon and, G0/G1 arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206375

The role of c-myc in cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206375

Mouse liver tumorigenesis: models, mechanisms, and relevance to human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206375

Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206375

Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206375

Activation of c-myc by woodchuck hepatitis virus insertion in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206375

Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206375

Amplification of c-myc in hepatocellular carcinoma: correlation with clinicopathologic features, proliferative activity and p53 overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206375

Specific association of human telomerase activity with immortal cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206375

Hepatocarcinogenesis in woodchuck hepatitis virus/c-myc mice: sustained cell proliferation and biphasic activation of insulin-like growth factor II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206375

Control of the cell cycle and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206375

Preliminary results of interferon-alpha therapy on woodchuck hepatitis virus-induced hepatocarcinogenesis: possible benefit in female transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206375

Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206375

Interferon-beta gene therapy inhibits tumor formation and causes regression of established tumors in immune-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206375

Role in nude mice of interferon and natural killer cells in inhibiting the tumorigenicity of human hepatocellular carcinoma cells infected with hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206375

Expression of c-myc gene in human hepatoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206375

The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206375

Direct activation of TERT transcription by c-MYC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206375

Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206375

Expression of c-Myc, c-Fos, and c-jun in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206375

Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206375

Interferon-alpha-mediated prevention of in vitro apoptosis of chronic lymphocytic leukemia B cells: role of bcl-2 and c-myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206375

7 January 2021

Nucleotide sequence of a cloned woodchuck hepatitis virus genome: comparison with the hepatitis B virus sequence.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206375

7 January 2021

Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206375

7 January 2021

Telomerase activity of needle-biopsied liver samples: its usefulness for diagnosis and judgement of efficacy of treatment of small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206375

7 January 2021

Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206375

7 January 2021

High-dose and long-term therapy with interferon-alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206375

7 January 2021

Identifiers

1 reference

release_bnj3vyf4tzdldifas4pxighpqa

6 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bnj3vyf4tzdldifas4pxighpqa

24 November 2022

mapped directly with Wikidata item

1 reference